As the Council meets to continue negotiating the budget for 2014 – 2020, senior industrialists, R&D administrators, university vice chancellors, Nobel prize winners and grass roots scientists insist the proposed €80B Horizon 2020 budget must be approved
It’s a virtuous circle: New approval processes put in place by the European Medicines Agency are de-risking drug development, promoting investment in early-stage biotech and meeting unmet medical needs, says Paul Morton
As the number one priority for ICT research, the 10-year FET Flagship projects in graphene and computer modelling of the brain announced this week are guaranteed €1B each - regardless of any cuts in the proposed €80B Horizon 2020 programme
The reform of data protection will lead to a surge of innovation in products and services and make the public sector more efficient, the Commission promises. But this won’t happen if ICT skills continue to be neglected
Willow trees cultivated for green energy can yield up to five times more biofuel if they grow diagonally, compared with those that are allowed to grow naturally up towards the sky.
Six of the world’s most prestigious public drug discovery organisations are joining forces in a bid to improve the conversion rate of basic research into much-needed new therapies
Universities have a pivotal role to play in responding to the Grand Challenges, fostering innovation and creating growth and social wellbeing. How should these institutions respond to this task? asks Lauritz B. Holm-Nielsen, President of Euroscience and Rector of Aarhus University, Denmark
Now is not the time to cut funds for large-scale experimentation. The current economic dilemma of the EU is a golden opportunity to enable innovation breakthroughs at a system level, says Ioan Ciumasu
It’s up to MEPs to ally with the Commission and stop the European Council cutting the proposed €80B research programme, Máire Geoghegan-Quinn, R&D Commissioner, tells the European Parliament as negotiations reach a head
Following a positive ruling on patents and a decision to maintain funding for embryonic stem cell research in Horizon 2020, things are looking up for regenerative medicine. Now further support is needed to deliver on the therapeutic potential, experts say in a Science|Business Webinar
Sweden has a reputation for great research – but policy leaders there are sounding an alarm about a decline in quality. A new study has implications for policy makers across Europe.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.